The Search for Pharmacologically Active Compounds Among the 2-Dialkylaminobenzimidazoles


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Heating of substituted benzimidazole-2-sulfonic acids in the presence of excess quantities of secondary amines was used to synthesize dialkylaminobenzimidazoles. Experimental studies of potential antiarrhythmic, antiaggregation, hemorheological, AT1 angiotensin- and NHE-1-inhibiting, and antiserotonin activity identified active compounds. 1[-2-(5-Methyl)benzimidazole]pyrrolidine had greater NHE-inhibiting activity than zoniporide. 1-{[2-(5-Methoxy)benzimidazole]-4-N-methyl}piperazine dihydrochloride had greater antiaggregatory activity than acetylsalicylic acid, while 1-[2-(5-methyl)benzimidazole]piperidine was as active as cyproheptadine in terms of 5-HT2A antagonistic activity. 1-(2-Benzimidazole)pyrrolidine and 1-[2-(5-chloro) benzimadazole pyrrolidine dihydrochlorides had 5-HT3 antagonist activity equal to that of tropisetron..

About the authors

O. N. Zhukovskaya

Science Research Institute of Physical and Organic Chemistry, Southern Federal University

Author for correspondence.
Email: zhukowskaia.ol@yandex.ru
Russian Federation, Rostov-on-Don

V. A. Anisimova

Science Research Institute of Physical and Organic Chemistry, Southern Federal University

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Rostov-on-Don

A. A. Spasov

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd; Volgograd

D. S. Yakovlev

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd; Volgograd

N. A. Gurova

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd

A. F. Kucheryavenko

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd

O. A. Salaznikova

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd

V. A. Kuznetsova

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd; Volgograd

D. V. Mal’tsev

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd; Volgograd

A. A. Brigadirova

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd; Volgograd

Ya. V. Morkovina

Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd

O. A. Solov’eva

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd

V. V. Gurova

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd

E. V. Reznikov

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
Russian Federation, Volgograd


Copyright (c) 2017 Springer Science+Business Media, LLC

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies